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Abstract
Background: We explore and compare the advantages and disadvantages of different operating methods for a
peripheral iridectomy (PI) for phakic posterior chamber implantable contact lens (ICL) implantation in patients with
dark-brown irides.
Methods: Forty-six patients completed this prospective comparative study. Neodymium: yttrium-aluminum-garnet
(Nd:YAG) PI was performed in 15 patients (30 eyes) 2 weeks prior to surgery (YAG PI group). Surgical PI was performed
in 17 patients (34 eyes) 2 weeks prior to the ICL implantation (preoperative PI group), and intraoperative PI was
performed during ICL implantation in 14 patients (28 eyes) (intraoperative PI group). The postoperative recovery of
visual acuity, intraoperative complications, operation duration, and patients’ visual disturbances were compared.
Results: Compared with the preoperative BCVA, the uncorrected visual acuity (UCVA) at 1 week was markedly restored
in the preoperative PI group (P = 0.004). UCVA in the three groups of patients had all recovered well at 1 and 3 months
after ICL implantation and were significantly better than the preoperative BCVA (all P < 0.01). In the YAG PI group, iris
bleeding occurred in nine eyes (30.0 %) and 14 eyes (46.7 %) had pigment dispersion; these values were significantly
higher than those in the preoperative PI group (5.9 and 14.7 %, respectively, both P = 0.01). In the intraoperative PI
group, elevated high intraocular pressure occurred in four eyes (14.3 %), and eight eyes (28.6 %) had varying degrees of
pigment dispersion after ICL implantation.
Conclusions: For patients with dark-brown irides, surgical PI performed 2 weeks prior to the implantation facilitated
better postoperative recovery of visual acuity.
Trial registration: Current Controlled Trials ISRCTN35178162. Retrospectively registered March 4th, 2013.
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Background
Implantable contact lenses (ICLs) are phakic posterior
chamber intraocular lenses used for the treatment of
high myopia, hyperopia, and astigmatism, and are one of
the major recent innovations in refractive surgery.
Implantation of these lenses can significantly improve
visual acuity and quality, [1] and their safety and efficacy
have been confirmed.
In early studies of ICL surgery, there were reports [1–3]
that peripheral iridectomy (PI) could effectively prevent
pupillary block and subsequent high intraocular pressure
(IOP) after ICL implantation. Currently, most surgeons
perform preoperative neodymium:yttrium-aluminum-gar-
net (Nd:YAG) laser peripheral iridectomy (YAG PI), which
is also recommended by the manufacturers of ICLs.
However, the incidence of pupillary block remains at 4.0–
11.1 % [4–6]. The timely application of YAG lasers, which
enlarge the iris incision, or increasing the number of iris
incisions can effectively relieve pupillary block and reduce
IOP [4, 7]. Some studies suggested that PI effectively
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prevent pupillary block [8–10]. The size of the iris
incision should be large but should not cause the iris
to be penetrable by light or cause diplopia and other
complications [8–10].
Most Asians have thick, dark-brown irides, which
makes it difficult to create two unblocked and large
holes with a YAG laser. Chun et al. [11] reported that in
ten eyes of eight patients with dark-brown irides
(12.3 %), narrowing or obstruction of the laser iridotomy
of 50 % or more was observed 6 months postoperatively
and required additional laser treatments. The reason for
the narrowing or obstruction was dark-brown pigment
epithelium regeneration; therefore, intraoperative PI was
recommended. Pesando et al. [12] applied traditional
intraoperative PI for patients with brown irides and
achieved good results. In the present study, we
performed a prospective comparison of different PI
approaches for ICL implantation in patients with dark-
brown irides. Our results provide a better understanding
of the advantages and disadvantages of the various
approaches.
Methods
This study was a prospective comparative study
retrospectively registered with Current Controlled
Trials (ISRCTN35178162) on March 4th, 2013 (http://
www.isrctn.com/ISRCTN351781620. The study was
approved by the ethical committee of the ChengDu
Military General Hospital (Sichuan, China). A written
informed consent was obtained from participant. The
study was carried out in accordance to the principle
of the Declaration of Helsinki.
Patient selection and grouping
From January 2011 to June 2012, 60 patients (120 eyes)
with high myopia were treated at the ChengDu Military
General Hospital and were enrolled in this study. Inclu-
sion criteria were: 1) dark brown irides; 2) aged between
18 and 45 years; 3) high myopia, with preoperative di-
opter had to be between−9.50 D and−22.0 D (spherical
equivalent); 4) inoperable by LASIK; 5) anterior chamber
depth >2.8 mm; 6) no abnormalities of the cornea, angle
structure, IOP, or peripheral retina on routine examin-
ation; 7) anterior chamber angle was open; and 8)
endothelial cell count was >2500 cells/mm2. Patients
were excluded if they had any other eye disorders (e.g.,
glaucoma, cataract, retinal degeneration, dry eye syn-
drome, etc.) or any systemic disorders that could affect
the surgical outcomes (e.g., Sjogren’s syndrome, Behcet’s
syndrome, etc.).
Finally, 58 patients (116 eyes) were included, and
divided into three groups: 1) YAG PI before ICL
implantation (Nd:YAG PI was performed 2 weeks prior
to ICL implantation) group included 19 patients (38
eyes); 2) PI before ICL implantation (PI was performed
2 weeks prior to the ICL implantation) group included
20 patients (40 eyes); and 3) intraoperative PI during
ICL implantation (PI was performed during ICL
implantation) group included 19 patients (38 eyes).
Surgery
Best-corrected visual acuity (BCVA) was assessed pre-
operation. All YAG PI procedures and all PI and ICL im-
plantations were performed by the same surgeon (Yan
Wu). The ICMV4 ICL/T-ICL (Toric ICL) lens from
STAAR Surgical Co. (Monrovia, CA, USA) were used in
all patients. The operation duration was recorded.
YAG PI was performed 2 weeks prior to ICL implant-
ation surgery. Pilocarpine drops (2 %) were applied three
times for miosis 20 min prior to laser surgery. The two
iridectomy holes were made at the 10:30 and 1:30
positions, separated by approximately 90°, in the middle
of the peripheral areas under the eyelids. To prevent iris
bleeding and pigment dispersion, standard argon laser
settings (0.1–0.2 s duration, 50 mm spot size, 700 to
1500 mW) were initially used to form a crater in the iris
stroma. After deep stromal iris penetration or the first
plume of iris pigment epithelium release, the Nd:YAG
laser (1.0 mJ, single burst, with power increased as
needed) was immediately used to achieve iris perforation
and remove the iris pigment epithelium. The diameter
of each hole was approximately 0.8 mm. Complete pene-
tration of the pigment epithelium was confirmed by
transillumination.
For surgical PI, PI was performed 2 weeks prior to ICL
implantation surgery. Pilocarpine drops (2 %) were
applied three times for miosis 20 min prior to PI sur-
gery. Firstly, above the 12 o’clock position, a conjunctival
incision was made 2 mm to the keratoconjunctival limus
to dissect the lower conjunctival edge, forming a con-
junctival flap with its bottom located at the conjunctival
limus. Secondly, a 3-mm corneal incision was made at
the corneal limbus beneath the conjunctival flap. Subse-
quently, iris forceps were inserted through the corneal
incision to clamp and partially pull the surrounding iris
outside the cornea; the iris was partially resected and the
incision was about 1–2 mm. Finally, after repositioning
the iris, the iris pigment layer was checked and the
penetrating resection was performed. The conjunctival
incision was closed with 10-0 suture.
Two weeks after undergoing the two aforementioned
PI approaches, a 3.2-mm main corneal incision was
made at the temporal side of the transparent corneal
limbus for ICL implantation. Two auxiliary corneal
incisions were made at the 12:00 and 6:00 positions. A
routine implantation of the ICL lens was performed,
followed by carbachol injection for miosis.
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For intraoperative PI during ICL implantation, a 3.2-
mm corneal incision was made at the 12:00 position
during ICL implantation surgery. Two auxiliary corneal
incisions were made at the 3:00 and 9:00 positions. The
main corneal incision was shorter than a conventional
corneal incision because the PI needed to be performed
simultaneously. The ICL was implanted through the
main corneal incision and then rotated to a horizontal
orientation. After miosis with carbachol, the PI was
performed at the 12:00 position. The diameter of each
hole was approximately 1.0–2.0 mm. The corneal
incision was sutured once or not at all based on the
different conditions.
Outcomes
The primary outcome was the time to eyesight recovery.
The secondary outcome was the number of complications
(pigment dispersion, iris bleeding, elevated IOP, etc.).
Postoperative care and follow-up
TobraDex was given four times/day for 3 days after YAG
PI and surgical PI. All patients received applications of
TobraDex four times/day for 3 days after ICL implant-
ation. The dosage of TobraDex was reduced once every
4 days and stopped 16 days after ICL implantation.
Levofloxacin eye drops were applied four times/day for
1 week after ICL implantation.
Follow-up was completed 1 day, 1 week, and 2 weeks
after YAG PI and surgical PI, and 1 day, 1 week, 1 month,
and 3 months after ICL implantation. Follow-up examina-
tions included assessments of IOP, BCVA, postoperative
recovery of uncorrected visual acuity (UCVA) (logarithm
of the minimum angle of resolution [LogMAR]), and
patient’s acceptance and satisfaction.
Complications
Complications were compared among the three iridec-
tomy approaches and included iris bleeding, iris prolapses,
pigment dispersion, visual disturbances, and elevated IOP
(measured using noncontact tonometers). Pigment disper-
sion was qualitatively checked during slit-lamp examin-
ation. Normal dispersion appeared as scattered pigment
deposition on the crystalline lens surface after preopera-
tive PI or on the ICL surface after ICL implantation. The
visual disturbance questionnaire was administered to the
participants to inquire whether they had experienced any
of the following either before or after the iridotomy or
after ICL implantation: halo, diplopia, crescent, ghost
image, glare, spots, shadows, blurring, or other visual
disturbances. Patients with postoperative IOP >21 mmHg
or an increase >5 mmHg over the preoperative IOP were
considered to have elevated IOP.
Statistical analysis
SPSS 13.0 statistical software (SPSS Inc., Chicago, IL,
USA) was used for data analysis. Categorical data are
expressed as frequency and were compared using the
Chi-square test or the Fisher exact test, as appropriate.
Normally distributed continuous variables are presented
as mean ± standard deviation and were compared
one-way analyses of variance (ANOVA). Paired t tests
were used to compare pre- and postoperative visual
acuity. P < 0.05 was considered statistically significant.
Results
Baseline characteristics of the patients
Fifty-eight patients were included in the study, and 12
patients were lost to follow-up (four patients in the YAG
PI before ICL implantation group; three patients in the
PI before ICL implantation group; five patients in the PI
during ICL implantation). Finally, 46 completed the
study, including 15 patients that underwent YAG PI
before ICL implantation group (30 eyes), 17 patients (34
eyes) that underwent PI before ICL implantation group,
and 14 patients (28 eyes) that underwent PI during ICL
implantation. The characteristics of the patients are pre-
sented in Table 1. The patients were aged 19–41 years
(P = 0.65 among the three groups). Gender distribution
was similar (P = 0.16 among the three groups). There
was no significant difference in diopter of the patients’
eyes and IOP before therapy among the groups (P = 0.43
and P = 0.69, respectively, among the three groups).
Visual acuity recovery
There was no significant difference of the preoperative
BCVA among the three groups (all P > 0.05) (Table 2).
On postoperative day 1 after YAG PI, two of the 30 eyes
(6.7 %) in the YAG PI group had a decreased BCVA
caused by incomplete absorption of blood in the anterior
chamber. On postoperative 1 day after ICL implantation,
the UCVA in the YAG PI group and the preoperative PI
group achieved the same level compared to preoperative
BCVA (P = 0.22 and P = 0.53, respectively). However, in
the intraoperative PI group, the UCVA was significantly
lower than the preoperative BCVA (P = 0.04) on the first
day after ICL implantation and recovered to the pre-
operative level at 1 week (P = 0.67).
Compared with the preoperative BCVA, the UCVA at
1 week was markedly restored in the preoperative PI
group (P = 0.004). However, there was no significant
difference compared with the YAG PI group (P = 0.76).
The improvements in the UCVA were better in the
preoperative PI and YAG PI groups compared with the
intraoperative PI group 1 week after ICL implantation
(both P < 0.05). The UCVA in the three groups of
patients had all recovered well at 1 and 3 months after
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ICL implantation and were significantly better than the
preoperative BCVA (all P < 0.01) (Table 2).
Complications
Surgical complications are presented in Table 3. In the
YAG PI group, nine of the 30 eyes (30.0 %) had iris
bleeding during laser application, and the laser treat-
ment had to be stopped for two eyes (one eye in two pa-
tients). TobraDex was administered, and both eyes were
bandaged. Laser treatment was performed the next day
after the blood was partially absorbed. Among the 34
eyes in the preoperative surgical PI group, two eyes
(5.9 %) had a small amount of bleeding during surgical
PI, which was significantly less than in the YAG PI group
(P = 0.01) (Table 3). Follow-up exams on postoperative
day 1 showed that bleeding was completely absorbed.
None of the patients experienced iris bleeding during
ICL implantation.
Among the 28 eyes in the intraoperative PI during ICL
implantation group, iris prolapse occurred in two eyes
(7.1 %). Both were successfully repositioned.
Fourteen eyes (46.7 %) in the YAG PI group had a
varying degree of pigment dispersion that almost
completely disappeared by the time of ICL surgery
2 weeks later. Among the 34 eyes in the preoperative
PI group, five eyes (14.7 %) had a small amount of
pigment dispersion, which was less than in the YAG
PI group and was absorbed more quickly (P = 0.01)
(Table 3). The dispersed pigment had almost
completely disappeared 1 week after surgery. Only
two eyes in the YAG PI group and three eyes in the
preoperative PI group had a small amount of iris
pigment dispersion during ICL implantation, which
was completely absorbed in the first week after
surgery.
Only two individuals in this study reported visual
disturbances. One saw shadows in one eye immediately
after preoperative surgical PI, but it had improved at the
following follow-up examination. This patient had an
exposed iridotomy. The other patient had received YAG
PI and complained of glare in both eyes after ICL
implantation, but this improved over time.
Table 1 Demography and clinical characteristics of the patients with high myopia and dark brown irides according with the different
peripheral iridectomy (PI) approaches
Variables YAG PI before ICL implantation
(n = 15)
PI before ICL implantation
(n = 17)
PI during ICL implantation
(n = 14)
P
Age (mean ± SD) (range), years 25.9 ± 7.4 (19–41) 26.5 ± 4.9 (19–36) 26.0 ± 5.8 (19–35) 0.65
Sex (M/F) 8/7 10/7 8/6 0.16
Diopter −14.44 ± 3.54 −14.17 ± 2.88 −14.72 ± 3.35 0.43
IOP (mean ± SD), mmHg 12.5 ± 1.4 13.2 ± 1.8 13.4 ± 2.1 0.69
YAG PI before implantable contact lens (ICL) implantation group: Neodymium:yttrium-aluminum-garnet (Nd:YAG) laser peripheral iridectomy (YAG PI) was performed
2 weeks prior to the ICL implantation. PI before ICL implantation group: PI was performed 2 weeks prior to the ICL implantation. PI during ICL implantation group: PI
was performed during ICL implantation
ICL implantable contact lenses, SD standard deviation, M male, F female
Table 2 Recovery of UCVA post-ICL Implantation for the different PI approaches
Group Number of eyes Pre-operative
BCVA
Post-operative UCVA
1 day 1 week 1 month 3 months
YAG PI before ICL implantation 30 0.55 ± 0.20 0.48 ± 0.10 0.63 ± 0.13 0.75 ± 0.20 0.80 ± 0.21
P (vs. preoperative BCVA) 0.22 0.10 0.006 <0.001
PI before ICL implantation 34 0.53 ± 0.10 0.51 ± 0.12 0.67 ± 0.19 0.76 ± 0.24 0.78 ± 0.23
P (vs. preoperative BCVA) 0.53 0.004 <0.001 <0.001
PI during ICL implantation 28 0.56 ± 0.15 0.46 ± 0.16 0.54 ± 0.13 0.75 ± 0.20 0.80 ± 0.18
P (vs. preoperative BCVA) 0.04 0.67 <0.001 <0.001
P1 0.73 0.41 0.76 0.91 0.81
P2 0.84 0.63 0.02 0.97 1.00
P3 0.46 0.24 0.01 0.87 0.78
Note Data are shown as mean ± SD
Pre-operative BCVA and postoperative UCVA was present as logarithm of the minimum angle of resolution [LogMAR]
BCVA best-corrected visual acuity, UCVA uncorrected visual acuity
P1: YAG PI before ICL implantation vs. PI before ICL implantation
P2: YAG PI before ICL implantation vs. PI during ICL implantation
P3: PI before ICL implantation vs. PI during ICL implantation
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None of the patients experienced pupillary block. In
the YAG PI group, six of the 30 eyes (20.0 %) had an
elevated IOP on postoperative 1 day (IOP >21 mmHg or
an increase >5 mmHg compared with baseline); the
highest IOP value was 25 mmHg. No medication was
given, and the IOP returned to a normal level 1 week
after surgery. Two eyes from the YAG PI group had
increased IOP 1 day after ICL implantation (22 and
23 mmHg, respectively), and recovered on postoperative
week 1 without any medication. However, the other two
eyes had increased IOP during the first postoperative
week of examination (21 and 23 mmHg, respectively). A
steroid-induced elevation of IOP was considered, and
IOP returned to normal after cessation of steroid hor-
mone. In the preoperative surgical PI group, elevated
IOP was observed in two eyes after the preoperative PI
and was noted in only one eye on the first day after ICL
implantation (23 mmHg) (Table 3). The IOP returned to
normal without special treatment. Four eyes (14.3 %) in
the intraoperative PI during ICL implantation group had
an elevated IOP on the first day after ICL implantation
(19, 21, 22, and 24 mmHg, respectively). The IOP
returned to normal 1 week after surgery without special
treatment (Table 3).
Operation duration
The duration of the ICL implantation operation in the
YAG PI group was 27.2 ± 5.7 min (20–36 min) compared
to 29.8 ± 5.6 min (21–39 min) in the preoperative PI
group (P > 0.05). The operation duration of intraoperative
PI during ICL was 45.3 ± 7.0 min (35–55 min) (Table 3).
Discussion
These results strongly suggest that surgical PI performed
2 weeks prior to ICL implantation facilitates better
postoperative recovery of visual acuity. The YAG PI
method has been recommended by the STAAR Surgical
Co. as one of the main approaches for PI, but the major-
ity of previous surgeries were performed on European
patients, whose irides are typically blue or gray and thus
contain less pigment than those of Asian patients. In
addition, the irides of Europeans are generally thinner
compared with those of Asians, making them easier to
access via laser. In Asian patients, it is difficult to simul-
taneously make two large, unblocked holes due to severe
pigment dispersion, which is considered to be a strong
risk factor for increased IOP [13]. Brandt et al. [14] and
Sanchez-Galeana et al. [15] described cases with pig-
mentary glaucoma secondary to implantation of a phakic
posterior chamber intraocular lens. Chun et al. [11]
indicated that the pigment in all quadrants increased
because of laser iridotomy when performed on dark-
brown irides. When the PI is performed, mechanical
injury caused by scissors is less than that caused by the
YAG laser. In this study, the incidence of pigment dis-
persion in the preoperative PI group was significantly
less compared with that in the YAG PI group.
Rosen et al. [2] reported that patients with brown iri-
des were more likely to develop a pupillary block, but
the reason was not defined in the article. In the study by
Chun et al. [11], peripheral iridotomies were gradually
occluded or narrowed by ≥50 % in ten eyes (12.3 %),
with regeneration of dark-brown iris pigment epithelium
Table 3 Comparison of iridectomy complications, ICL implantation complications, and duration of ICL implantation operations in
different PI approach
Variables YAG PI before ICL implantation PI before ICL implantation PI during ICL implantation Pa
Number of eyes 30 34 28
Iridectomy Complications, n (%)
Iris bleeding 9 (30.0) 2 (5.9) - 0.01
Pigment dispersion 14 (46.7) 5 (14.7) - 0.01
Elevated IOP 6 (20.0) 2 (5.9) - 0.08
Decreased BCVA 2 (6.7) 0 (0.0) 0.22
ICL Implantation Complications, n (%)
Iris prolapse 0 (0.0) 0 (0.0) 2 (7.1) 1.00
Pigment dispersion 2 (6.7) 3 (8.8) 8 (28.6) 0.34
Visual disturbances 2 (6.7) 1 (2.9) 0 (0.0) 0.35
Iris bleeding 0 (0.0) 0 (0.0) 0 (0.0) 1.00
Elevated IOP 2 (6.7) 1 (2.9) 4 (14.3) 0.35
Duration of ICL implantation operation, min 27.2 ± 5.7 29.8 ± 5.6 45.3 ± 7.0 0.06
Note: Data are shown as mean ± SD or proportion, as appropriate
aPI before ICL implantation vs. YAG PI before ICL implantation
-: Not assessed. IOP: intraocular pressure
The IOP and BCVA were assessed on postoperative 1 day
Elevated IOP: postoperative IOP >21 mmHg or IOP increased by >5 mmHg over the preoperative IOP
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around the laser iridotomy opening. The authors hypothe-
sized that this may have been due to sterile chronic
inflammation from a compromised anterior blood-ocular
barrier. Therefore, the iridotomy size in dark-brown irides
for ICL implantation should be slightly larger than that
used in a conventional laser iridotomy. It requires a high
level of skill to use a laser to make holes in a dark-brown
iris. Improper operation of a YAG laser can cause iatro-
genic trauma to the crystalline lens and zonules [12, 16].
Pesando et al. [12] also stopped using laser treatment on
patients with brown irides; rather, they used a traditional
iridectomy and achieved good results. The incision for
surgical PI is much larger than that of the YAG PI, making
it difficult to develop a viscoelastic material-induced
obstruction and iridectomy closure can be caused by iris
edema, postoperative inflammation, exudative membrane
blocking, and pigment granule block [7]. Therefore, surgi-
cal PI is theoretically more effective in preventing
pupillary block. In this study, all three PI approaches
successfully prevented pupillary block.
Selection of the iridotomy site is particularly im-
portant for preventing visual disturbances after PI
[10]. The traditional PI sites recommended by the
STAAR Surgical Company are located approximately
90° apart at 10:30 and 1:30 positions. Although care
was taken to locate the PI sites under the eyelids, the
incidence of the visual disturbances was 7.0–9.9 % in
previous reports [11, 17]. Spaeth et al. [17] reported
that most of the iridotomies placed outside the 11:00
to 1:00 range were fully or partially exposed, which
put the patients at a higher risk for visual distur-
bances than if the iridotomy had been fully covered
by the eyelids. Theoretically, a corneal incision made
at the 12:00 position would have good upper eyelid
coverage, and this prevents glare or double vision.
However, locating the iridotomy at the 12:00 position
does not assure complete coverage of the iridotomy.
In eyes with lid retraction, it is important to consider
carefully the likelihood of visual disturbances. We did
not observe a significant difference between the YAG
PI and surgical PI approaches.
It is recommended in the traditional YAG PI that two
peripheral iridotomies should be located superiorly
approximately 90° apart to decrease the likelihood of
occlusion by the ICL haptics [1, 18]. However, variations
on this principle have also been described. In his later
cases, Gonvers et al. [10] performed only one iridotomy
on the 12:00 meridian. For surgical PI, the corneal inci-
sion is also made at the 12:00 position. Because the
current ICL and T-ICL lenses are designed for a hori-
zontal orientation, the ICL lens cannot move on the lens
surface after it is in place. Therefore, it is theoretically
impossible for the lens edge to block the PI incision at
the 12:00 position.
Iris bleeding can necessitate a second laser surgery or
lead to vision loss, which will increase mental and
financial burden on the patients, especially those with
inconvenient transportation options or high transporta-
tion costs. Surgical PI is a brief and simple procedure,
which would achieve good predictability of the outcome
and postoperative recovery. The patients had no obvious
discomfort on the following day, and they had no
changes in their vision during this study. Therefore, all
of the patients in the preoperative surgical PI group in
the present study were more satisfied than those in the
other groups.
A single surgery to complete peripheral iridectomy
and ICL implantation can reduce the psychological and
economic burden to patients. However, due to the ex-
tended surgery duration and complex operating proced-
ure, the inflammatory responses to the surgery are more
serious. Studies from a U.S. clinical research team using
ICL to treat high myopia [19] and results reported Jimé-
nez-Alfaro et al. [20] described that the ICL postopera-
tive inflammatory reaction was mainly caused by the
surgery itself. Therefore, a shorter surgery duration and
simpler operating procedure may result in less injury, a
reduced postoperative reaction, and better vision recov-
ery. In this study, it was more likely for the patients to
develop iris prolapse in the intraoperative PI during ICL
implantation group because of the shorter main corneal
incision, although there was no statistical significance
compared with the other two PI methods (P > 0.05). The
surgeon must be highly skilled to reduce the operation
duration and decrease the rate of complications.
There are some limitations to this study. It was per-
formed at a single institution, so the numbers of patients
in the three groups were relatively small. In addition, all
of our patients were healthy, so it is unclear if similar ef-
fects would be achieved in patients with comorbidities.
In addition, for the third operation approach, the ICL
had to be rotated during the operation and this could in-
crease the risk of damage; however, plenty of viscoelastic
agent was injected to protect the crystal during oper-
ation and there was no case of complication induced by
rotation. Thus, rotation was practical if the operation
was carefully conducted. Finally, during the design and
process of the present study, the newest central hole
type ICL V4c, which is designed to eliminate the need
for PI, was not on the market yet. Nevertheless, further
large-scale studies are necessary to confirm our findings.
Conclusions
The results of the present study suggest that it might be
preferable that patients with dark-brown irides undergo
surgical PI 2 weeks prior to ICL implantation. Different
PI methods should be selected according to each patient
characteristics (e.g., iris color and thickness, and corneal
Wu et al. BMC Ophthalmology  (2016) 16:51 Page 6 of 7
pannus extent), patient transportation and economic
situations, hospital situations, and surgeon proficiency to
minimize complications, reduce patient stress, and
financial burden, and to achieve the greatest degree of
patient satisfaction.
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